부산대학교 도서관

We report hemodialysis patient treated by arterial administration of SMANCS. A 71-year-old male was referred to our hospital for dialysis therapy. A mosaic-patterned mass with halo (5cm in diameter) was discovered on screening ultrasonography. CT scan of the abdomen revealed tumor in the S8 segment of the liver. Hepatic functions were well preserved. After obtaining informed consent, the first arterial administration of SMANCS (4mg) with lipiodol was performed in July 1996. The second arterial administration of SMANCS (6mg) with lipiodol was performed along with emboliztion in April 1997. There were no serious complications, while undergoing hemodiafiltrtion or hemodialysis three times per week. It was suggested that arterial administration therapy with SMANCS can be performed safely in patient undergoing chronic hemodialysis.